Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Pain, Intractable 1Neoplasms 1Mucositis 1Leukemia 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

Specimen Handling 8venetoclax 7Azacitidine 6Cyclophosphamide 5Biopsy 4fludarabine phosphate 3Tacrolimus 3Etoposide 3fludarabine 2Stem Cell Transplantation 2Mitoxantrone 2Melphalan 2Magnetic Resonance Spectroscopy 2Cytarabine 2vactosertib 1regorafenib 1prednylidene 1methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside Pt(II) 1iadademstat 1gilteritinib 1eltrombopag 1deltacortene 1decitabine and cedazuridine drug combination 1cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV)) 1brincidofovir 1beta-apocarotenoid-14',13'-dioxygenase 1azathiopurine 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1aldesleukin 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Hydromorphone × Other hematologic neoplasm × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡